links remain unclear. We show that late-differentiated T cells in 20 ICL patients displayed defective TCR responses and aging markers similar to those found in T cells from elderly subjects. Intrinsic T-cell defects were caused by increased expression of dual-specific phosphatase 4 (DUSP4). Normalization of DUSP4 expression using a specific siRNA improved
CD4
+ T-cell activity in ICL, as this restored TCR-induced ERK activation and increased the expression of the co-stimulatory molecules CD27 and CD40L. Conversely, repeated TCR stimulation led to defective signaling and DUSP4 overexpression in control CD4 + T cells. This was associated with gradual acquisition of a memory phenotype and curtailed by DUSP4
silencing. These findings identify a premature T-cell senescence in ICL that might be caused by chronic T-cell activation and a consequential DUSP4-dependent dampening of TCR signaling.
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INTRODUCTION
Idiopathic CD4 lymphopenia (ICL) is a rare disorder characterized by an absolute CD4 + T-cell count < 300/mm 3 or < 20% of the total T cells on more than one cell count, in the absence of infection with HIV-1/2 or HTLV-1/2 or other identified causes of lymphopenia 1, 2 . ICL is most frequently diagnosed in adults, although pediatric cases have been reported [2] [3] [4] [5] . Patients may
show opportunistic infections as a result of a profound deficiency in cell-mediated immune responses 2, 6, 7 . Although the molecular mechanisms underlying this heterogeneous syndrome are still unclear, loss-of-function mutations have been described for genes encoding various regulators of TCR diversity and signaling 3, 4, [8] [9] [10] . In line with the weak adaptive immunity in ICL, antigen-induced lymphoproliferation, cytokine production and vaccination responses are diminished 3, 11, 12 .
ICL might result from defective thymic production or output of T cells, exacerbated peripheral consumption, or any combination of these [4] [5] [6] [12] [13] [14] [15] [16] [17] [18] . Cell-intrinsic or -extrinsic factors have been identified in ICL that may participate in the perturbation of CD4 + T-cell homeostasis. These include altered responses to homeostatic cytokines, such as IL-2, IL-7 and CXCL12 12, 15, 16 , and an enhanced susceptibility of ICL-derived T cells to undergo apoptosis 17, 18 .
Activation and turnover markers are higher in ICL CD4 + T cells and the expression levels of these markers inversely correlate with blood CD4 + T-cell counts 6 . Abnormal T-cell activation was also associated with high levels of microbial translocation products in ICL plasma 19 . Thus, persistent stimulation by an unidentified pathogen may be one cause of the chronic immune activation and preferential loss of naive T cells in ICL 11 .
Mechanistic studies have pointed to defective TCR signal transduction in ICL. In one case, low Lck/p56 activity accounted for weak CD4 + T-cell proliferation in response to CD3/TCR stimulation 20 . Additionally, a dominant-negative missense mutation has been identified in one patient that targets the signaling adaptor protein Unc119 required for Lck
For personal use only. on July 16, 2017 . by guest www.bloodjournal.org From 4 transport and activation, and thus for TCR-triggered responses 8 . X-linked mutations in the magnesium transporter gene 1 (MAGT1) were also described in two related patients, suggesting a role for Mg 2+ as an intracellular second messenger that couples TCR activation to intracellular effectors 3 . These findings raise the possibility that persistent T-cell activation in ICL leads to dampened TCR-mediated signaling and proliferation.
To gain further insight into the functional pathways implicated in ICL pathophysiology, we compared the gene expression profiles of CD4 + T cells sorted from the blood of ICL patients and control groups of age-matched healthy subjects and patients with CD4 + T-cell lymphopenia secondary to sarcoidosis (SARC) 21 . These arrays enabled us to identify an ICLrelated genetic signature with predominant involvement of two gene groups, one related to TCR response and the other strikingly associated with T-cell aging. Among the first group, expression of the dual-specific phosphatase 4 (DUSP4), which negatively regulates MAPK activation, was increased similar in this respect to CD4 + T cells from elderly subjects.
Functional studies further linked this overexpression to accelerated T-cell senescence in ICL.
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Sample processing
Whole blood phenotyping of T-cell subsets was performed as described 22 . Isolation, cryopreservation, thawing and staining of CD4 + T cells and PBMCs were performed as described 23,24 using mAbs detailed in Supplemental Methods. CFSE-loaded PBMCs or CD4 + T cells were either left untreated or stimulated once, twice or three times on anti-CD3/-CD28 Abcoated plates for 5 days. Data were collected on a Fortessa flow cytometer.
Microarray analysis
Total RNA was isolated from CD4 + T-cell pellets obtained from healthy, SARC and ICL subjects using the miRNAeasy mini kit (Qiagen). Microarray analysis was performed using Affymetrix Human Exon 1.0 ST according to the manufacturer's recommendations. Dataset analysis and visualization were done using EASANA ® , which is based on GenoSplice FAST DB ® annotations 25, 26 . Array data are available at Gene Expression Omnibus (accession number: GSE56998). For details, see Supplemental Methods.
Methods for PCR, DUSP4 silencing, immunoblot, ELISA, telomerase activity, telomere length and chemotaxis assays as well as statistical analyses are described in Supplemental Methods.
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RESULTS
Expansion of circulating TEMRA T cells in ICL
We analyzed 20 patients with ICL (Table 1) . CD4 + T-cell counts were significantly lower in ICL patients than in age-matched healthy subjects, and to a lesser extent, these counts were lower than in untreated and uninfected patients with lymphopenia secondary to SARC (Supplemental Table 1 ). CD8 + T-cell counts were lower in ICL patients than in healthy individuals, although at a lower level of significance. B-cell counts were also significantly lower in ICL patients, although this did not correspond to lower Ig levels in patient sera. Our cohort was clinically heterogeneous, as 40% of the patients were asymptomatic and 60%
presented with opportunistic infections typically observed in CD4 + T-cell deficiencies such as AIDS
27
. Four ICL patients suffered from dysimmune diseases.
Whole blood immunophenotyping indicated that circulating CD4 + and CD8 + T-cell lymphopenia in ICL predominantly affected naive cells (Table 2 and Supplemental Tables 2   and 3 ). Analyses of the memory T-cell compartment defined by CD45RA and CCR7 expression levels showed that the terminally differentiated effector memory (TEMRA, CD45RA + CCR7 -) subpopulation was expanded in ICL patients. Contraction of the naive subset and inflation of the TEMRA compartment both correlated with the degree of T-cell lymphopenia (Supplemental Figure 1 and Table 3 ). Impaired T-cell expression of CXCR4, which binds the chemokine CXCL12, was reported for six ICL patients 12 .
We assessed whether CXCR4 dysfunction extended to our larger cohort (Table 2 , Supplemental Figure 2 and Table   2 ). Compared to healthy and SARC T cells, we detected reduced levels of CXCR4 expression and chemotactic function in naive and activated-memory T cells from 17 of 20 ICL patients.
Low levels of CXCR4 expression correlated with the degree of T-cell lymphopenia. Therefore, ICL and SARC patients differ in peripheral T-cell subset distribution and CXCR4 status. Figure 1A and Supplemental Table 4 ) and ICL patients versus SARC patients (Supplemental Table 5 ). Comparisons between healthy and SARC individuals revealed only a few differentially regulated genes in the CD4 + T cells from SARC patients (Supplemental Table 6 ). Figure 1B and Supplemental Table 4 ).
To identify the canonical pathways differentially modulated in ICL, the ICL signature transcripts were subjected to Gene Ontology and KEGG pathway analyses. The T-cell genes differentially expressed in ICL were enriched in functional groups associated with telomere shortening, defective T-cell signaling, altered immune responses, impaired DNA repair, and p53 signaling ( Figure 1C ), which are related to cellular senescence. Subsequently, the ICL signature was compared to a list of genes known to change expression levels with increasing age in T cells 28 Figure 1D ). These results highlight an ICL-related transcriptional signature suggestive of a diminished TCR response and enhanced aging.
Decreased sensitivity to TCR stimulation in ICL T cells
Based on our transcriptomic analyses, we investigated the strength of the TCR signaling in ICL CD4 + T cells. These analyses were extended to include T cells from six nonagenarian subjects that, similar to ICL T cells, displayed an inflation of the TEMRA phenotype but exhibited normal to high levels of membrane CXCR4 expression and function (Tables 1 and 2 and   Supplemental Tables 2 and 3) 32-34
. First, we assessed TCR responsiveness by stimulating CFSE-loaded PBMCs from healthy, elderly, SARC and ICL subjects on anti-CD3/-CD28 Abcoated plates for 5 days (Figure 2A Figure 3C and D). These findings indicate that the TCR response is diminished in ICL T cells. This low level of TCR activation is comparable to that found in elderly subjects, whose T cells are known to be senescent, and in SARC patients, whose T cells are known to be anergic 31, 35 .
Accelerated T-cell senescence in ICL
Reduced TCR signaling intensity and impaired T-cell expansion in response to TCR For personal use only. on July 16, 2017 . by guest www.bloodjournal.org From 9 stimulation are features of T-cell aging or anergy 36 . We thus performed phenotyping analyses for four key markers of T-cell senescence: the co-stimulatory molecules CD27 and CD28 and the NK-cell markers CD57 and KLRG-1. As reported 34 , CD4 + T cells from elderly subjects exhibited lower CD27 and CD28 expression levels and higher CD57 and KLRG-1 expressions than those of healthy subjects ( Figure 3A and B). This was associated with higher expression of the cytotoxic molecule granzyme B. Although expression levels of these markers were scattered over a large range among ICL patients, the percentages of CD27 Telomerase is a ribonucleoprotein DNA polymerase consisting of two components: TERT, a catalytic reverse transcriptase, and TERC, an RNA template that encodes the telomeric DNA repeats. We found both of these to be down-regulated in ICL ( Figure 1 ). The level of telomerase activity was lower in ICL and elderly PBMCs than in healthy or SARC PBMCs ( Figure 3C ) and this was associated with shortened telomere length ( Figure 3D ). To distinguish these observations from exhaustion, we analyzed in ICL T cells the expression levels of the inhibitory receptors PD-1 and CTLA-4 41 . We observed no increase in any of those markers on CD4 + T cells from ICL patients as compared to those on healthy cells (Supplemental Figure 5A and B). This was associated with no change in the expression of PRDM1 that encodes BLIMP-1, a transcriptional repressor highly expressed in exhausted T cells and responsible for the increased expression of co-inhibitory receptors (Supplemental Figure 5C 
No impact of opportunistic or chronic infections on T-cell senescence in ICL
There was no significant correlation between the age or T-cell count of ICL patients and the expression levels of senescent markers (Supplemental Table 7 ). We sought to determine whether T-cell changes in ICL could result from opportunistic or chronic infections. When asymptomatic patients (n=8) were compared to those who had experienced opportunistic infections (n=12), no significant difference was obtained for the senescence markers (Table 3) .
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Repeated TCR stimulation leads to DUSP4 overexpression
One feedback mechanism that regulates the nuclear activities of the MAPK pathway and dampens TCR signaling involves the DUSP family of phosphatases 44 . Increased expression of DUSP6 and DUSP4 with age has been reported in naive and memory CD4 + T cells respectively 29, 31 . To elucidate the mechanism underlying the decrease in TCR-induced ERK activation in expanded-memory T cells from ICL patients, we investigated the DUSP4 status.
As determined by real-time PCR, CD4 + T cells from elderly and ICL subjects exhibited higher DUSP4 mRNA levels than those of healthy and SARC individuals ( Figure 4A ). This was also detected for DUSP6 in accordance with transcriptomic analyses ( Figure 1D ). 
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DUSP4 but not DUSP6 expression ( Figure 4D ). Two rounds of TCR stimulation were sufficient to give rise to DUSP4 mRNA levels similar to those detected in non-manipulated elderly and ICL cells ( Figure 4A ). DUSP4-overexpressing T cells displayed increased expression of HLA-DR in contrast to the strong decline in surface expression of CD45RA, CXCR4, and the co-stimulatory molecules CD27 and CD40L ( Figure 4E and F) . This expression pattern is consistent with a terminally differentiated phenotype 29, 34 . These findings suggest that memory-activated CD4 + T cells respond poorly to successive TCR stimuli, and that the consequent increase in DUSP4 expression constitutes negative regulatory feedback.
DUSP4 silencing improves T-cell activity in ICL
To determine whether DUSP4 negatively regulates TCR signaling, the activation-induced increase in the level of DUSP4 mRNAs was silenced in healthy CD4 + T cells after two rounds of stimulation. Quantitative PCR and immunoblot analyses revealed that DUSP4 knockdown following DUSP4 knockdown ( Figure 5E ). These results indicate that intrinsic CD4 + T-cell defects in ICL partially depend on high expression of DUSP4, and that its silencing was able to reverse T-cell unresponsiveness.
For
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DISCUSSION
In this study, we found that the characteristics of T cells from 20 ICL adults closely mimic Tcell alterations that normally occur during aging. First, ICL T cells displayed a decrease in the naive subset and an expansion of the TEMRA subpopulation in the blood. This phenotype is observed in elderly individuals, for whom it could reflect the cumulative exposure of T cells to pathogens throughout life 36, 46 . However, the decreased frequency of CD45RA For
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Interestingly, ICL resembles to HIV from a clinical view but also from the pathophysiological view with accelerated immune aging 51, 52 . Several studies have demonstrated that TEMRA T cells cannot halt telomere shortening because they lack the mechanisms that compensate for telomere erosion. One such mechanism is POT-1-mediated maintenance 36 , which is also altered in ICL T cells. Therefore, T-cell overstimulation may be one cause of the accelerated aging phenotype found in ICL T cells.
We , it would be interesting to determine whether lymphocytopenia could be uncoupled, or not, from T-cell senescence in patients carrying a gene mutation.
Although T cells from ICL and elderly subjects share several features, their CXCR4 expression levels were strikingly different, being tenfold lower in ICL than in older adult T cells. This might reflect either CXCR4 internalization following strong TCR activation 62 or a lack of CXCR4 recycling to the plasma membrane 12 . One interpretation is that CXCR4 is re- conceived and designed the study, found funding for the study and wrote the manuscript.
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For personal use only. Table 2 . Immunophenotyping of CD4 + T-cell populations.
Data are medians (ranges). SARC, sarcoidosis; ICL, idiopathic CD4 + T-cell lymphopenia; ns, not significant; MFI, mean fluorescence intensity. Using the protein tyrosine phosphatase isoform CD45RA and the chemokine receptor CCR7, CD4 + T cells were subdivided into naive (NV), central memory (CM), effector memory (EM), and terminally differentiated effector memory (TEMRA) subpopulations. *P < 0.05, **P < 0.005 and ***P < 0.0005 compared with healthy individuals or ^ significantly different compared with elderly subjects (as determined using the Mann-Whitney U-test). 
